Impact of management on the prognosis of pure uterine papillary serous cancer - A Taiwanese Gynecologic Oncology Group (TGOG) study

Gynecologic Oncology

Volumn 133, Issue 2, 2014, Pages 221-228

  Huang, Chia Yen ^a,b,c   Tang, Yun Hsin ^d,e   Chiang, Ying Cheng ^b,c   Wang, Kung Liahng ^f,g,h   Fu, Hung Chun ^d   Ke, Yu Min ⁱ   Lau, Hei Yu ^j,k   Hsu, Keng Fu ^l   Wu, Ching Hu ^m,n   Cheng, Wen Fang ^b,c  

^a CATHAY GENERAL HOSPITAL   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^c NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^d CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

^e CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^f MACKAY MEMORIAL HOSPITAL   (Taiwan)

^g NURSING AND MANAGEMENT COLLEGE   (Taiwan)

^h TAIPEI MEDICAL UNIVERSITY   (Taiwan)

ⁱ TAICHUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^j TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^k NATIONAL YANG MING UNIVERSITY   (Taiwan)

^l NATIONAL CHENG KUNG UNIVERSITY HOSPITAL   (Taiwan)

^m KAOHSIUNG MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

ⁿ KAOHSIUNG MUNICIPAL HSIAO KANG HOSPITAL   (Taiwan)

more..

Author keywords

Adjuvant therapy; Papillary serous carcinoma; Recurrence; Survival; Uterine cancer

Indexed keywords

CA 125 ANTIGEN; DOXORUBICIN; EPIRUBICIN; PACLITAXEL; PLATINUM;

ABDOMINAL RADIOTHERAPY; ADULT; AGED; ARTICLE; BODY MASS; BRACHYTHERAPY; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CLINICAL FEATURE; DIABETES MELLITUS; ELECTROCORTICOGRAPHY; ENDOMETRIUM CARCINOMA; FEMALE; FOLLOW UP; HUMAN; HYPERTENSION; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; LYMPH VESSEL METASTASIS; MAJOR CLINICAL STUDY; MENOPAUSE; MINIMAL RESIDUAL DISEASE; NULLIPARA; OUTCOME ASSESSMENT; OVERALL SURVIVAL; POSTOPERATIVE CARE; PRIORITY JOURNAL; RECURRENCE RISK; RETROSPECTIVE STUDY; SURVIVAL RATE; VAGINAL BRACHYTHERAPY; WHOLE PELVIC RADIOTHERAPY;

ADJUVANT THERAPY; PAPILLARY SEROUS CARCINOMA; RECURRENCE; SURVIVAL; UTERINE CANCER;

ADENOCARCINOMA, PAPILLARY; ADULT; AGED; AGED, 80 AND OVER; CHEMORADIOTHERAPY, ADJUVANT; COMBINED MODALITY THERAPY; DISEASE-FREE SURVIVAL; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; HYSTERECTOMY; KAPLAN-MEIER ESTIMATE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; TAIWAN; TREATMENT OUTCOME; UTERINE NEOPLASMS;

EID: 84899634684     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2014.02.010     Document Type: Article

References (31)

1. R. Siegel, D. Naishadham, and A. Jemal Cancer statistics, 2012 CA Cancer J Clin 62 2012 10 29
2. (TCRTF) TCRTF Cancer Registry Annual Report. Taipei: Department of Health, The Executive Yuan; 2010 2013
3. C.Y. Huang, C.A. Chen, Y.L. Chen, C.J. Chiang, T.H. Hsu, and M.C. Lin et al. Nationwide surveillance in uterine cancer: survival analysis and the importance of birth cohort: 30-year population-based registry in Taiwan PLoS One 7 2012 e51372
4. M. Hendrickson, J. Ross, P. Eifel, A. Martinez, and R. Kempson Uterine papillary serous carcinoma: a highly malignant form of endometrial adenocarcinoma Am J Surg Pathol 6 1982 93 108
5. V. Benito, A. Lubrano, O. Arencibia, E.E. Alvarez, L. Leon, and N. Medina et al. Pure papillary serous tumors of the endometrium: a clinicopathological analysis of 61 cases from a single institution Int J Gynecol Cancer 19 2009 1364 1369
6. R.E. Bristow, F. Asrari, E.L. Trimble, and F.J. Montz Extended surgical staging for uterine papillary serous carcinoma: survival outcome of locoregional (stage I-III) disease Gynecol Oncol 81 2001 279 286
7. S. Memarzadeh, C.H. Holschneider, R.E. Bristow, N.L. Jones, Y.S. Fu, and B.Y. Karlan et al. FIGO stage III and IV uterine papillary serous carcinoma: impact of residual disease on survival Int J Gynecol Cancer 12 2002 454 458
8. B.M. Slomovitz, T.W. Burke, P.J. Eifel, L.M. Ramondetta, E.G. Silva, and A. Jhingran et al. Uterine papillary serous carcinoma (UPSC): a single institution review of 129 cases Gynecol Oncol 91 2003 463 469
9. J.A. Rauh-Hain, W.B. Growdon, J.O. Schorge, A.K. Goodman, D.M. Boruta, and C. McCann et al. Prognostic determinants in patients with stage IIIC and IV uterine papillary serous carcinoma Gynecol Oncol 119 2010 299 304
10. W. Creasman Revised FIGO staging for carcinoma of the endometrium Int J Gynaecol Obstet 105 2009 109
11. M.B. Thomas, A. Mariani, W.A. Cliby, G.L. Keeney, K.C. Podratz, and S.C. Dowdy Role of cytoreduction in stage III and IV uterine papillary serous carcinoma Gynecol Oncol 107 2007 190 193
12. M.B. Thomas, A. Mariani, W.A. Cliby, G.A. Keeney, K.C. Podratz, and S.C. Dowdy Role of systematic lymphadenectomy and adjuvant therapy in stage I uterine papillary serous carcinoma Gynecol Oncol 107 2007 186 189
13. R.E. Bristow, L.R. Duska, and F.J. Montz The role of cytoreductive surgery in the management of stage IV uterine papillary serous carcinoma Gynecol Oncol 81 2001 92 99
14. M.L. Carcangiu, and J.T. Chambers Uterine papillary serous carcinoma: a study on 108 cases with emphasis on the prognostic significance of associated endometrioid carcinoma, absence of invasion, and concomitant ovarian carcinoma Gynecol Oncol 47 1992 298 305
15. L.C. Hwang, C.H. Bai, and C.J. Chen Prevalence of obesity and metabolic syndrome in Taiwan J Formos Med Assoc 105 2006 626 635
16. W.T. Creasman, M.F. Kohler, F. Odicino, P. Maisonneuve, and P. Boyle Prognosis of papillary serous, clear cell, and grade 3 stage I carcinoma of the endometrium Gynecol Oncol 95 2004 593 596
17. A. Gadducci, S. Cosio, F. Landoni, T. Maggino, P. Zola, and L. Fuso et al. Analysis of treatment failures and survival of patients with uterine papillary serous carcinoma: a Cooperation Task Force (CTF) Study Int J Gynecol Cancer 22 2012 1355 1360
18. W. Wang, V. Do, R. Hogg, G. Wain, A. Brand, and C. Bull et al. Uterine papillary serous carcinoma: patterns of failure and survival Aust N Z J Obstet Gynaecol 49 2009 419 425
19. A. Mariani, S.C. Dowdy, W.A. Cliby, M.G. Haddock, G.L. Keeney, and T.G. Lesnick et al. Efficacy of systematic lymphadenectomy and adjuvant radiotherapy in node-positive endometrial cancer patients Gynecol Oncol 101 2006 200 208
20. A.J. Chiang, K.J. Yu, K.C. Chao, and N.N. Teng The incidence of isolated para-aortic nodal metastasis in completely staged endometrial cancer patients Gynecol Oncol 121 2011 122 125
21. C.Y. Huang, C.M. Ho, Y.L. Chen, S.L. You, C.A. Chen, and W.F. Cheng Impact of lymphadenectomy in uterine endometrioid carcinoma Eur J Surg Oncol 39 2013 350 357
22. N.C. Lambrou, O. Gomez-Marin, R. Mirhashemi, H. Beach, E. Salom, and Z. Almeida-Parra et al. Optimal surgical cytoreduction in patients with stage III and stage IV endometrial carcinoma: a study of morbidity and survival Gynecol Oncol 93 2004 653 658
23. K.A. Moller, P.A. Gehrig, L. Van Le, A.A. Secord, and J. Schorge The role of optimal debulking in advanced stage serous carcinoma of the uterus Gynecol Oncol 94 2004 170 174
24. L.R. Duska, R. Berkowitz, U. Matulonis, M. Muto, A. Goodman, and J.F. McIntyre et al. A pilot trial of TAC (paclitaxel, doxorubicin, and carboplatin) chemotherapy with filgastrim (r-metHuG-CSF) support followed by radiotherapy in patients with "high-risk" endometrial cancer Gynecol Oncol 96 2005 198 203
25. A.L. Fields, M.H. Einstein, A.P. Novetsky, J. Gebb, and G.L. Goldberg Pilot phase II trial of radiation "sandwiched" between combination paclitaxel/platinum chemotherapy in patients with uterine papillary serous carcinoma (UPSC) Gynecol Oncol 108 2008 201 206
26. P.A. Gehrig, D.E. Morris, and L. Van Le Uterine serous carcinoma: a comparison of therapy for advanced-stage disease Int J Gynecol Cancer 14 2004 515 520
27. J.S. Low, E.H. Wong, H.S. Tan, S.P. Yap, E.J. Chua, and V.K. Sethi et al. Adjuvant sequential chemotherapy and radiotherapy in uterine papillary serous carcinoma Gynecol Oncol 97 2005 171 177
28. A.A. Secord, L.J. Havrilesky, D.M. O'Malley, V. Bae-Jump, N.D. Fleming, and G. Broadwater et al. A multicenter evaluation of sequential multimodality therapy and clinical outcome for the treatment of advanced endometrial cancer Gynecol Oncol 114 2009 442 447
29. H. Steed, L. Manchul, B. Rosen, A. Fyles, G. Lockwood, and S. Laframboise et al. Uterine papillary serous carcinoma: evaluation of multimodality treatment with abdominopelvic radiotherapy and chemotherapy Int J Gynecol Cancer 16 Suppl. 1 2006 278 285
30. J.K. Chan, A.E. Sherman, D.S. Kapp, R. Zhang, K.E. Osann, and L. Maxwell et al. Influence of gynecologic oncologists on the survival of patients with endometrial cancer J Clin Oncol 29 2011 832 838
31. D.M. Boruta II, P.A. Gehrig, A.N. Fader, and A.B. Olawaiye Management of women with uterine papillary serous cancer: a Society of Gynecologic Oncology (SGO) review Gynecol Oncol 115 2009 142 153